Engineered and chimeric nucleases
AssigneeMetagenomi, Inc.
InventorsBrian C. Thomas, Alan Brooks, Christopher Brown, Cristina Noel Butterfield, Daniela S.A. Goltsman, Jyun-Liang Lin, Isabel Nocedal, Morayma Temoche-Diaz
Life of this patent
Estimating the term…
Abstract
Disclosed herein are engineered nucleases and nuclease systems, including chimeric nucleases and chimeric nuclease systems. Engineered and chimeric nucleases disclosed herein include nucleic acid guided nuclease. Additionally disclosed herein are methods of generating engineered nucleases and methods of using the same.
Claims110
An engineered endonuclease, comprising:
- a) an N-terminal portion comprising a sequence having at least 80% sequence identity to SEQ ID NO:
- 696;
- and
- b) a C-terminal portion comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 697-721.
An engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862.
An engineered endonuclease comprising a sequence having at least 80% sequence identity to SEQ ID NO:
- 10.
An engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 109-110 and 2842-2854.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and to hybridize to a target nucleic acid sequence.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 109-110 and 2842-2854;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and to hybridize to a target nucleic acid sequence.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within an albumin gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 67-86.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a TRAC gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 119-138, 922-924, 972-991, 1088-1183, 1280-1320, 2390-2485, and 2582-2617.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a B2M gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 159-184.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a TRBC1 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 211-251.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a TRBC2 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 293-337.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within an ANGPTL3 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 383-477, 1392-1489, 2120-2215, and 2312-2350.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a PCSK9 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 573-587 and 1362-1376.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a VCP gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 723-738 and 755-762.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within an AAVS1 locus or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 928-949 and 1012-1049.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a GPR146 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 1588-1656.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within an APOA1 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 1726-1744, 1764-1774, 1866-1961 and 2058-2088.
An engineered nuclease system, comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a HAO1 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 611-633, 1789-1826, and 1827-1865.
A method of modifying an albumin gene comprising contacting the albumin gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the albumin gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 67-86.
A method of modifying a TRAC gene comprising contacting the TRAC gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the TRAC gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 119-138, 922-924, 972-991, 1088-1183, 1280-1320, 2390-2485, and 2582-2617.
A method of modifying a B2M gene comprising contacting the B2M gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the B2M gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 159-184.
A method of modifying a TRBC1 gene comprising contacting the TRBC1 gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the TRBC1 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 211-251.
A method of modifying a TRBC2 gene comprising contacting the TRBC2 gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the TRBC2 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 293-337.
A method of modifying an ANGPTL3 gene comprising contacting the ANGPTL3 gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the ANGPTL3 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 383-477, 1392-1489, 2120-2215, and 2312-2350.
A method of modifying a PCSK9 gene comprising contacting the PCSK9 gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the PCSK9 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 573-587 and 1362-1376.
A method of modifying a VCP gene comprising contacting the VCP gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the VCP gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 723-738 and 755-762.
A method of modifying an AAVS1 locus comprising contacting the AAVS1 locus using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the AAVS1 locus or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 928-949 and 1012-1049.
A method of modifying a GPR146 gene comprising contacting the GPR146 gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the GPR146 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 1588-1656.
A method of modifying an APOA1 gene comprising contacting the APOA1 gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within the APOA1 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 1726-1744, 1764-1774, 1866-1961 and 2058-2088.
A method of modifying a TRAC gene comprising contacting the TRAC gene using an engineered nuclease system comprising:
- a) an engineered endonuclease comprising a sequence having at least 80% sequence identity to any one of SEQ ID NOs:
- 1-27 and 771-862;
- and
- b) an engineered guide polynucleotide configured to form a complex with the endonuclease and comprising a spacer sequence configured to hybridize to at least a portion of a target nucleic acid sequence within a HAO1 gene or within an intron of an endogenous gene, the engineered guide polynucleotide comprising a sequence having at least 90% sequence identity to any one of SEQ ID NOs:
- 611-633, 1789-1826, and 1827-1865.
Dependencies are inferred from the claim text.